Vanguard Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,477,636
| Closed | -$401K | – | 4589 |
|
|
2022
Q3 | $401K | Sell |
1,477,636
-503,929
| -25% | -$220K | ﹤0.01% | 4273 |
|
|
2022
Q2 | $1.53M | Hold |
1,981,565
| – | – | ﹤0.01% | 3929 |
|
|
2022
Q1 | $2.12M | Buy |
1,981,565
+248,819
| +14% | +$452K | ﹤0.01% | 3932 |
|
|
2021
Q4 | $3.29M | Sell |
1,732,746
-2,626
| -0.2% | -$6.29K | ﹤0.01% | 3831 |
|
|
2021
Q3 | $5.22M | Hold |
1,735,372
| – | – | ﹤0.01% | 3629 |
|
|
2021
Q2 | $6.79M | Sell |
1,735,372
-136,437
| -7% | -$566K | ﹤0.01% | 3412 |
|
|
2021
Q1 | $9.49M | Buy |
1,871,809
+900,529
| +93% | +$4.67M | ﹤0.01% | 3171 |
|
|
2020
Q4 | $3.97M | Buy |
971,280
+30,576
| +3% | +$150K | ﹤0.01% | 3457 |
|
|
2020
Q3 | $4.57M | Sell |
940,704
-10,691
| -1% | -$58.4K | ﹤0.01% | 3194 |
|
|
2020
Q2 | $5.27M | Buy |
951,395
+65,232
| +7% | +$299K | ﹤0.01% | 3073 |
|
|
2020
Q1 | $2.91M | Buy |
886,163
+203,435
| +30% | +$1.07M | ﹤0.01% | 3193 |
|
|
2019
Q4 | $3.09M | Hold |
682,728
| – | – | ﹤0.01% | 3327 |
|
|
2019
Q3 | $2.84M | Buy |
682,728
+84,398
| +14% | +$305K | ﹤0.01% | 3331 |
|
|
2019
Q2 | $2.27M | Sell |
598,330
-1,901
| -0.3% | -$7.79K | ﹤0.01% | 3440 |
|
|
2019
Q1 | $2.52M | Buy |
600,231
+43,395
| +8% | +$152K | ﹤0.01% | 3376 |
|
|
2018
Q4 | $1.39M | Buy |
556,836
+62,218
| +13% | +$364K | ﹤0.01% | 3470 |
|
|
2018
Q3 | $3.61M | Buy |
494,618
+5,300
| +1% | +$23.2K | ﹤0.01% | 3343 |
|
|
2018
Q2 | $1.81M | Buy |
489,318
+44,073
| +10% | +$204K | ﹤0.01% | 3532 |
|
|
2018
Q1 | $1.71M | Sell |
445,245
-7,430
| -2% | -$31.2K | ﹤0.01% | 3518 |
|
|
2017
Q4 | $1.63M | Sell |
452,675
-32,501
| -7% | -$123K | ﹤0.01% | 3489 |
|
|
2017
Q3 | $1.92M | Sell |
485,176
-11,471
| -2% | -$52.7K | ﹤0.01% | 3414 |
|
|
2017
Q2 | $2.53M | Sell |
496,647
-42,702
| -8% | -$240K | ﹤0.01% | 3313 |
|
|
2017
Q1 | $3.72M | Buy |
539,349
+3,891
| +0.7% | +$30.4K | ﹤0.01% | 3170 |
|
|
2016
Q4 | $5.01M | Buy |
535,458
+39,894
| +8% | +$359K | ﹤0.01% | 3063 |
|
|
2016
Q3 | $4.85M | Buy |
495,564
+49,602
| +11% | +$669K | ﹤0.01% | 3028 |
|
|
2016
Q2 | $6.3M | Buy |
445,962
+31,762
| +8% | +$496K | ﹤0.01% | 2861 |
|
|
2016
Q1 | $5.79M | Buy |
414,200
+57,183
| +16% | +$839K | ﹤0.01% | 2889 |
|
|
2015
Q4 | $7.28M | Buy |
357,017
+77,946
| +28% | +$1.2M | ﹤0.01% | 2810 |
|
|
2015
Q3 | $3.67M | Buy |
279,071
+53,399
| +24% | +$886K | ﹤0.01% | 3108 |
|
|
2015
Q2 | $3.46M | Buy |
225,672
+32,343
| +17% | +$620K | ﹤0.01% | 3184 |
|
|
2015
Q1 | $3.86M | Buy |
193,329
+42,011
| +28% | +$939K | ﹤0.01% | 3115 |
|
|
2014
Q4 | $3.18M | Buy |
151,318
+8,975
| +6% | +$183K | ﹤0.01% | 3100 |
|
|
2014
Q3 | $2.65M | Buy |
142,343
+82,031
| +136% | +$1.49M | ﹤0.01% | 3146 |
|
|
2014
Q2 | $1.39M | Buy |
+60,312
| New | +$1.06M | ﹤0.01% | 3390 |
|
Vanguard Group's AGTC Position: Q4 2022 in Review
Vanguard Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 1,477,636 shares — an estimated $401K sold.
Vanguard Group first reported a position in AGTC in Q2 2014 and held it in 34 quarters. The position peaked at $9.49M in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Vanguard Group reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Vanguard Group sold 1,477,636 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $401K.
- Vanguard Group first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 34 quarters.
- Vanguard Group's Applied Genetic Technologies Corporation position peaked at $9.49M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.